GMPR2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.697400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.988600E-01
Normal-vs-Stage2
2.703000E-01
Normal-vs-Stage3
1.634350E-01
Normal-vs-Stage4
9.424200E-01
Stage1-vs-Stage2
7.898200E-01
Stage1-vs-Stage3
4.044600E-01
Stage1-vs-Stage4
4.170400E-01
Stage2-vs-Stage3
1.479630E-01
Stage2-vs-Stage4
5.439600E-01
Stage3-vs-Stage4
2.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.805200E-01
Normal-vs-AfricanAmerican
1.110830E-01
Normal-vs-Asian
2.090000E-01
Caucasian-vs-AfricanAmerican
4.268400E-01
Caucasian-vs-Asian
4.934800E-01
AfricanAmerican-vs-Asian
8.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.497200E-01
Normal-vs-Female
3.064800E-01
Male-vs-Female
7.947000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.545600E-01
Normal-vs-Age(41-60Yrs)
4.094800E-01
Normal-vs-Age(61-80Yrs)
2.026000E-01
Normal-vs-Age(81-100Yrs)
6.009800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.248400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.332000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.018000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.976000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.185600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.146050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.196150E-01
Normal-vs-Daily Drinker
3.357000E-01
Normal-vs-Weekly Drinker
2.127200E-01
Normal-vs-Occasional Drinker
8.107000E-01
Normal-vs-Social Drinker
1.810170E-01
Non Drinker-vs-Daily Drinker
3.150600E-01
Non Drinker-vs-Weekly Drinker
9.661200E-01
Non Drinker-vs-Occasional Drinker
1.072070E-02
Non Drinker-vs-Social Drinker
2.395400E-01
Daily Drinker-vs-Weekly Drinker
4.295000E-01
Daily Drinker-vs-Occasional Drinker
1.467610E-01
Daily Drinker-vs-Social Drinker
8.956600E-01
Weekly Drinker-vs-Occasional Drinker
4.767900E-02
Weekly Drinker-vs-Social Drinker
3.458000E-01
Occasional Drinker-vs-Social Drinker
1.454420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.564200E-02
Normal-vs-Grade 2
2.432500E-02
Normal-vs-Grade 3
1.025780E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.090200E-01
Grade 1-vs-Grade 3
2.651700E-02
Grade 1-vs-Grade 4
8.564200E-02
Grade 2-vs-Grade 3
6.987600E-02
Grade 2-vs-Grade 4
2.432500E-02
Grade 3-vs-Grade 4
1.025780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.844000E-01
Normal-vs-NonDiabetic
1.873050E-01
Diabetic-vs-NonDiabetic
9.081600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.127220E-01
Normal-vs-NoPancreatitis
2.342200E-01
Pancreatitis-vs-NoPancreatitis
3.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.655600E-01
Normal-vs-N1
2.920000E-01
N0-vs-N1
9.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.425600E-01
Normal-vs-TP53-NonMutant
2.550400E-01
TP53-Mutant-vs-TP53-NonMutant
1.780440E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
